Molson Coors Beverage

TAP · NYSE

$40.20+$0.87 (+2.21%)TodayMarket closed ·
Prev close $39.33

TAP analyst rating

HoldConsensus of 17 analysts over the last 12 months. 18% rate it a buy.
  • Strong buy0
  • Buy3
  • Hold12
  • Underperform2
  • Sell0

12-month price target · 23 analysts

Average $46.32 (+15.2% upside)

Low
$33.33
Now
$40.20
High
$64.05

Upgrades and downgrades

The latest rating actions, newest first

TAP analyst upgrades, downgrades and rating actions
FirmDateActionRating
BarclaysOct 16, 2026MaintainsUnderweight
CitigroupOct 14, 2026MaintainsNeutral
TD CowenOct 13, 2026MaintainsHold
Wells FargoOct 5, 2026MaintainsEqual-Weight
JP MorganAug 10, 2026MaintainsNeutral
UBSAug 7, 2026MaintainsNeutral
NeedhamAug 7, 2026MaintainsBuy
Piper SandlerAug 7, 2026MaintainsNeutral
UBSJul 16, 2026MaintainsNeutral
CitigroupJul 14, 2026MaintainsNeutral

The case for and against

Updated Oct 14, 2026

Bull case

Molson Coors Beverage is supported by a resilient portfolio of leading brands like Miller, Coors, and Blue Moon, plus licensing partnerships that expand exposure to premium and beyond-beer categories through brands such as Heineken, Fever-Tree, and Coca-Cola. Despite a challenging U.S. beer market with category growth down 4.2%, the company is expected to improve sequentially in 2H26 as Monaco scales, share performance improves, and shipments outpace retail sell-through. Its $450 million productivity program, combined with MG&A relief, bolt-on M&A, and expected 2027-28 savings flow-through, should help offset soft volumes and support earnings, even as 2026 revenue is modeled at $11.05 billion and EPS at $4.70.

Bear case

Molson Coors Beverage is facing a weak fundamental setup because its core North America business, which generates nearly 80% of revenue, is seeing soft category trends and a meaningful volume decline, with Americas volume down 7.7% and total company organic revenue down 4.6% in 2Q26. Management expects 2026 revenue of -1% to +1% and EPS declines of -15% to -11%, while analysts also model -2% to -1% organic sales declines and -2% to -1% annual EPS declines in 2026-28, signaling limited growth visibility. At the same time, the company faces heavy cost pressure from Midwest Premium, which rose about 85% in 2026 and adds at least $130M of incremental costs, creating margin risk even if price/mix remains supportive.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.